Next Article in Journal
Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii: A Multicenter Study in China
Next Article in Special Issue
Validating Use of Electronic Health Data to Identify Patients with Urinary Tract Infections in Outpatient Settings
Previous Article in Journal
The Bristol Sponge Microbiome Collection: A Unique Repository of Deep-Sea Microorganisms and Associated Natural Products
Previous Article in Special Issue
Antimicrobial Stewardship in General Practice: A Scoping Review of the Component Parts
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Content and Mechanism of Action of National Antimicrobial Stewardship Interventions on Management of Respiratory Tract Infections in Primary and Community Care

1
Center for Behavior Change, University College London, Alexandra House, 7–19 Queens Square, London WC1N 3AZ, UK
2
Public Health England Behavioral Insights (PHEBI), Public Health England, Wellington House, 133–155 Waterloo Road, London SE1 8UG, UK
3
NHS England and NHS Improvement, Wellington House, 1st Floor, 133-155 Waterloo Road, London SE1 8UG, UK
4
Chelsea and Westminster Hospital NHS Foundation Trust, London SW10 9NH, UK
5
Public Health England, Primary Care Unit, Twyver House, Bruton Way, Gloucester GL1 1DQ, UK
*
Author to whom correspondence should be addressed.
Antibiotics 2020, 9(8), 512; https://doi.org/10.3390/antibiotics9080512
Submission received: 22 June 2020 / Revised: 6 August 2020 / Accepted: 10 August 2020 / Published: 13 August 2020
(This article belongs to the Special Issue Antimicrobial Stewardship in Primary Care)

Abstract

:
A major modifiable factor contributing to antimicrobial resistance (AMR) is inappropriate use and overuse of antimicrobials, such as antibiotics. This study aimed to describe the content and mechanism of action of antimicrobial stewardship (AMS) interventions to improve appropriate antibiotic use for respiratory tract infections (RTI) in primary and community care. This study also aimed to describe who these interventions were aimed at and the specific behaviors targeted for change. Evidence-based guidelines, peer-review publications, and infection experts were consulted to identify behaviors relevant to AMS for RTI in primary care and interventions to target these behaviors. Behavior change tools were used to describe the content of interventions. Theoretical frameworks were used to describe mechanisms of action. A total of 32 behaviors targeting six different groups were identified (patients; prescribers; community pharmacists; providers; commissioners; providers and commissioners). Thirty-nine interventions targeting the behaviors were identified (patients = 15, prescribers = 22, community pharmacy staff = 8, providers = 18, and commissioners = 18). Interventions targeted a mean of 5.8 behaviors (range 1–27). Influences on behavior most frequently targeted by interventions were psychological capability (knowledge and skills); reflective motivation (beliefs about consequences, intentions, social/professional role and identity); and physical opportunity (environmental context and resources). Interventions were most commonly characterized as achieving change by training, enabling, or educating and were delivered mainly through guidelines, service provision, and communications & marketing. Interventions included a mean of four Behavior Change Techniques (BCTs) (range 1–14). We identified little intervention content targeting automatic motivation and social opportunity influences on behavior. The majority of interventions focussed on education and training, which target knowledge and skills though the provision of instructions on how to perform a behavior and information about health consequences. Interventions could be refined with the inclusion of relevant BCTs, such as goal-setting and action planning (identified in only a few interventions), to translate instruction on how to perform a behavior into action. This study provides a platform to refine content and plan evaluation of antimicrobial stewardship interventions.

1. Introduction

The number of serious infections resistant to treatment is increasing and antimicrobial resistance (AMR) is one of the major risks facing public health [1,2]. In Europe, AMR is associated with approximately 25,000 deaths per year and 700,000 globally [3]. It is estimated that a continued rise in resistance would cost the world 100 trillion USD by 2050 if AMR is not addressed effectively [4]. The Interagency Coordination Group on Antimicrobial Resistance report to the WHO recommends countries reduce the need for antimicrobials and enhance their responsible and prudent use, as well as advises the use of behavior change interventions aimed at both public and professionals [5].
One of the major modifiable factors contributing to AMR is inappropriate use and overuse of antimicrobials such as antibiotics [3]. In the UK, 72% of antibiotics are prescribed in General Practice (GP) [6]. Although consumption of antibiotics in UK primary care decreased by 16.7% between 2014–2018 [6], this more than a third higher than some other European countries, such as Sweden and The Netherlands [7].
The first step in intervention design is to specify the behavior(s) the intervention is aimed at changing [8]. Both prescribers’ and patients’ behavior is associated with the inappropriate use and misuse of antibiotics [9]. Prescribers may issue unnecessary prescription of antibiotics to patients with self-limiting infections [10] or inappropriately select the type and duration of the medication [11]. A European Center for Disease Prevention and Control survey of healthcare professionals reported that only 63% agreed or strongly agreed they have a key role in helping control antibiotic resistance [12]. Public misconceptions on the indications and effectiveness of antibiotics are prevalent with only 43% of respondents in a European Commission survey of general public views of antimicrobial resistance knowing that antibiotics are ineffective against viruses [13]. Patient’s expectations around the use of antibiotics can influence the GP’s prescribing behavior and lead to inappropriate prescribing and overuse [14].
The optimization of prescribing practice through antimicrobial stewardship (AMS) programs was one of seven key priority areas for action in the UK Five Year Antimicrobial Resistance Strategy 2013 to 2018 [15]. AMS includes various initiatives to tackle AMR and improve patient safety, for example: establishing optimal standards for antimicrobial use within the healthcare setting, interventions aiming to promote appropriate prescribing, and reviewing the impact of the AMS initiatives. Multifaceted AMS programs aimed at the public, as well as frontline healthcare professionals, are needed to tackle AMR [16,17]. Moreover, there is evidence that the culture of the healthcare organization may also influence the prescribing behavior [18].
A number of policies and interventions have been developed and nationally implemented. However, it is unclear if these interventions focus on the behaviors that would optimally impact on AMR and whether they use the full range of intervention types and policy levers available. It is also unclear if the current program of AMS interventions aim to change behavior through the mechanisms hypothesized to be effective in behavior change theory.
Pinder et al. [19] conducted a review of 150 studies and identified key behaviors that should be targeted in AMS interventions and proposed potential opportunities for new interventions. They also identified a small number of nationally implemented interventions that were mapped to the barriers and facilitators found in the literature. To optimize the potential of AMS programs, the behaviors and populations targeted by these interventions, as well as their content and mechanisms of action of these needs, to be articulated. Tools developed in behavioral science can support such work.
The Behavior Change Wheel (BCW) [20] is a synthesis of 19 frameworks of behavior change and can be used to characterize the content of interventions. The BCW is linked to a model of behavior, COM-B (Capability, Opportunity, Motivation–Behavior), which can be used to identify the mechanisms of action of interventions. The Theoretical Domains Framework (TDF) can be considered an elaboration of COM-B (see Table S1). McParland [21] used the TDF and the Behavior Change Technique (BCT) Taxonomy version 1 (BCTTv1) [22], a classification of “active ingredients” that are used to change behavior, to describe public awareness AMR interventions. The authors concluded that there is a clear potential for improvement of interventions. However, the review focused on 20 peer-reviewed studies of interventions aimed at the general public only. There remains a need to review nationally implemented interventions that target both healthcare professionals, as well as the public. To the authors’ knowledge, the BCW has not been used to review AMS interventions already implemented nationally across England to analyze and improve the AMS initiatives.
The overarching aim of this study was to build on the work of Pinder et al. [19] by characterizing nationally implemented AMS primary care programs to identify any gaps in coverage and opportunities for refinement. The specific aims were to:
  • identify the behaviors and target populations related to AMS for respiratory tract infection (RTI) in primary care;
  • identify interventions targeting AMS for RTI in primary care;
  • describe their content using the Behavior Change Wheel and BCT;
  • describe their mechanisms of action of interventions using COM-B and TDF.
Research identifying gaps between the influences and behavioral content of AMS interventions to highlight potential avenues for improvement will be reported in a separate study.

2. Methods

We drew on the following sources to identify behaviors relevant to patient self-care and/or appropriate antibiotic advice for the management of signs and symptoms of self-limiting respiratory tract infections:
  • A literature review and high level behavioral analysis of antibiotic prescribing in the public, primary and secondary care [19].
  • Relevant official guidance [17,23,24,25,26,27,28,29,30,31,32].
  • UK AMR five-year strategy [15].
  • Consultation with experts in epidemiology, pharmacy, infection management, and behavioral science.
  • Self-limiting respiratory tract infections and symptoms of respiratory tract infections, included acute cough/acute bronchitis, common colds, flu, acute otitis media, acute otitis externa, (middle) ear infections, acute sinusitis, sore throat (tonsillitis), pharyngitis, laryngitis, bronchitis, respiratory tract infection, tracheitis, and acute rhinitis.
To describe the content of nationally adopted AMS interventions in England, authors identified potentially relevant programs for inclusion based on their knowledge of the policy area, consultation with key stakeholders and review of relevant documentation.
We included interventions implemented nationally in England between January 2014 and February 2018, where the primary objective was antimicrobial stewardship activities related to patient self-care and/or appropriate antibiotic advice for the management of respiratory tract infections. Interventions were excluded if local implementation only had occurred. Two authors (AS and VdLM) sought descriptions of the interventions from publicly available material and in some instances contacted the program leads for elaboration and to ensure accurate descriptions.
Providers and commissioners were defined as follows: providers defined as professionals in organizations providing care for the management of signs and symptoms of RTIs, e.g., Trusts, General Practice, private providers, and commissioners defined as professionals in organizations commissioning services for the management of signs and symptoms of self-limiting RTIs, e.g., Local Authorities, Clinical Commissioning Groups, Clinical Services Units, and National Health Service England.

Data Extraction Tools

The BCW and BCTTv1 were used to classify intervention content identified in intervention materials or descriptions of interventions into intervention types, policy options (see Table S2), and BCTs.
To describe the intervention mechanisms of action, we were guided by three matrices—two linking BCTs to TDF domains [33,34] and one linking intervention types to COM-B and TDF [8] to determine from the BCTs we identified in interventions, which influences on behavior (characterized using COM-B and TDF) the BCTs were likely to be targeting.

3. Data Analysis

For each intervention, we recorded the total number of COM-B components and TDF domains, intervention types, policy options, and BCTs, and calculated the mean and range. We recorded the number of interventions in which each COM-B component, TDF domain, intervention types, BCT, and policy option was present (mean and range).

Interrater Reliability

One researcher (LA) conducted 100% of the coding, and a second researcher (AS) coded 20% to establish reliability. Percentage agreement for each section of intervention coded was calculated where both coders assigned the same code(s) to the same section of intervention material. PABAK (Prevalence And Bias-Adjusted Kappa) statistic [35] was used to assess the presence or absence of codes within each intervention. This statistic adjusts for shared bias in the coders’ use of options and high prevalence of negative agreement, i.e., when both coders agree that codes are not present. Interrater reliability of 0.60–0.79 = ‘substantial’ reliability, >0.80 = ‘outstanding’ [36].

4. Results

We identified 32 behaviors related to AMS for RTI in primary care. These are summarized in Table 1 (see Table S3 for the sources from which behaviors were identified). Five were patient behaviors, 11 related to prescribers, five were community pharmacist behaviors, two related to providers, one related to commissioners), and eight related to both providers and commissioners.
A total of 83 interventions were identified for content analysis of nationally adopted AMS interventions in England. Thirty-nine met the inclusion criteria (Table 2 with the target group(s)). Of the 44 excluded interventions: 31 were not aimed at the relevant behaviors or target groups; five were information, general media, or links to resources only; four were not nationally implemented; and four were part of other already identified interventions.
Of the 39 included interventions, 15 were aimed at patients/public, 22 at prescribers, eight at community pharmacy staff, 18 at providers, and 18 at commissioners. Almost half of the interventions (n = 19) were aimed at one target group only, nine were aimed at two target groups and three interventions (Public Health England’s Antibiotic Guardian [37], TARGET Antibiotics Toolkit (Treat Antibiotics Responsibly, Guidance, Education, Tools) [38], and British Society for Antimicrobial Chemotherapy’s Antibiotic Action [39]) were aimed at all five target groups. A mean of 5.8 behaviors were targeted by interventions.
Patient interventions were largely aimed at encouraging self-care and reducing requests for antibiotics for self-limiting respiratory tract infections (e.g., Antibiotic Guardian, Treat Yourself Better [40]). Interventions aimed at prescribers targeted various behaviors, but most commonly the behavior that antibiotic prescriptions ‘should be written only when there is a clear clinical benefit’ (e.g., UK Department of Health and Public Health England’s Antimicrobial Prescribing and Stewardship Competencies [41]), followed by the behavior to ‘provide a backup prescription where appropriate’ (e.g., TARGET). The behavior targeted least was that prescribing antibiotics following a telephone consultation should only occur in exceptional circumstances (e.g., NICE Infection Prevention and Control (QS61) [27]). Interventions targeting pharmacies were largely aimed at provision of self-care advice (e.g., NICE Antimicrobial stewardship: changing risk-related behaviors in the general population NICE guideline (NG63) [23]) and sharing written resources with the patient (e.g., The Learning Pharmacy [42]). The most frequently targeted behavior for providers and commissioners was ‘monitor antibiotic prescribing in relation to local and national resistance patterns or targets’ (e.g., TARGET).

4.1. Interrater Reliability

The kappa ranged from 0.60 to 0.89 suggesting good to very good inter-rater reliability. The PABAK was from 0.75 to 0.95, suggesting substantial to outstanding agreement. Kappa and PABAK for behaviors, mechanism of action (COM-B, TDF), and intervention content (intervention types, policy options, BCTs) are presented in Table 3.

4.2. Intervention Types Identified in Interventions

Eight of a potential nine intervention types were identified across all interventions (Table 4). The mean number of intervention types per intervention was 3 (range 1–6). Figure 1 shows the number of types identified in interventions split by target group. Patient interventions often used education, training and persuasion. Prescriber interventions included seven out of nine intervention types, primarily training, education, and persuasion. Pharmacy interventions frequently used enablement and training but also used education and persuasion covering four of the nine possible intervention types. Provider and commissioner interventions were most frequently training, enablement, and education. No interventions used restriction.

4.3. Policy Options Identified in Interventions

Five policy options were identified across the 39 interventions. ‘Service provision,’ e.g., website, was the most frequently identified (15/39), followed by ‘guidelines,’ e.g., NICE guidance, (14/39), ‘communication / marketing,’ e.g., poster, (10/39), ‘legislation,’ i.e., Health and Social Care Act (1/39), and ‘fiscal measures’, i.e., NHS Quality Premiums for CCGs (1/39). Figure 2 shows the number of policy options identified in interventions split by target group. No interventions were delivered through environmental/social planning or regulation. Patient interventions were commonly delivered using communication/marketing and service provision, while prescriber interventions were delivered mainly through guidelines, followed by service provision. Provider and commissioner interventions were delivered largely through guidelines and service provision, with some communication/marketing and legislation.

4.4. BCTs Identified in Interventions

A total of 30 BCTs were identified across all interventions with the mean number of 4 per intervention (range 1–14) as shown in Table 5. Figure 3 shows the number of BCTs identified in interventions split by target group. Patient and prescriber interventions most commonly used the BCTs ‘information about health consequences’ and ‘instruction on how to perform the behavior’. The most frequently used BCT in pharmacy, provider, and commissioner interventions was ‘instruction on how to perform the behavior.’
The frequency of mechanisms of action identified in interventions is outlined in Table 6.
Figure 4 and Figure 5 show the influences on behavior targeted in interventions split by target groups. The most frequently targeted influence on behavior was psychological capability for all target groups. For patients, prescribers and commissioners reflective motivation was the next most frequently targeted influence on behavior, whilst for pharmacy and provider interventions, it was physical opportunity. Automatic motivation and social opportunity were infrequently targeted. Only one intervention aimed to change physical capability.
The TDF domain, knowledge, was the most frequently targeted influence for all target groups; for pharmacy interventions, ‘environmental context and resources’ was equally prevalent. For patients and prescribers, the next most commonly targeted influences were beliefs about consequences and skills. For pharmacy it was social and professional role and identity and skills. Interventions for providers and commissioners also targeted behavioral regulation and environmental context and resources.
A summary of interventions, the behaviors and groups they target, and their content and mechanism of action is given in Table A1. The same information structured by behavior is provided in Table S4.

5. Discussion

The overall aim of current research was to gain a detailed understanding of existing AMS national interventions, to pinpoint key areas of focus, and potential gaps and opportunities for future interventions. This study identified behaviors and target populations related to AMS for RTI in primary care and characterized the content and mechanism of action of interventions of nationally implemented AMS interventions targeted in primary care (patients and public, prescribers, providers, commissioners, and pharmacy).
Of the 32 behaviors identified, approximately one-third were related to prescribers, one third related both to providers and commissioners, and the remaining third was evenly split between patients and community pharmacy staff. The focus of interventions for patients was on self-care and not requesting antibiotics at consultations. The majority of prescriber interventions encouraged ‘prescribing only when there is a clear clinical benefit’, ‘giving alternative self-care advice’, ‘providing a back-up prescription where appropriate’, and ‘following local antibiotic formularies.’ Few interventions addressed limiting prescribing following telephone consultation and undertaking point of care tests (POCT), such as CRP. Given the potential for POCT to reduce inappropriate prescribing [67] related behaviors should be considered in the design or refinement of future interventions. Pharmacy interventions were aimed at provision of self-care advice, sharing written resources and checking antibiotic prescriptions comply with local guidance and querying those that do not. Provider and commissioner interventions focused on ‘monitoring prescribing in relation to local and national resistance patterns’, and ‘commissioning, developing, and implementing interventions to support AMS’.
We identified 39 national AMS interventions for RTI in primary care. Interventions were typically in the form of ‘service provision’, such as a website or clinical guidelines followed by communications/marketing. Approximately three-quarters of the interventions were ‘training’ mainly using the BCT, ‘instruction on how to perform the behavior’ and includes training programs, such as TARGET [38], Stemming the Tide of Antibiotic Resistance (STAR) e-learning [44], Managing Acute Respiratory Tract Infections (MARTI) e-learning [45], and Public Health England’s ‘Beat the Bugs’ course [46]. The same proportion served were classed as ‘education’ mostly frequently using the BCT ‘information about health consequences.’ Twenty-five interventions were classed as ‘enabling,’ delivered most frequently with the BCT ’adding objects to the environment,’ such as the provision of a checklist to prevent antimicrobial misuse. Eighteen interventions used ‘persuasion’ mostly through the BCT ‘credible source,’ for example, providing an experienced GP’s view of implementing delayed prescriptions. Few to no interventions used restriction, environmental restructuring, modeling and coercion.
The most frequently identified mechanisms of action, by which interventions aimed to change behavior, were ‘psychological capability’ (‘knowledge’, ‘skills’ and ‘behavioral regulation’); ‘reflective motivation’ (‘beliefs about consequences’ and ‘intention’) and ‘physical opportunity’ (‘environmental context and resources, e.g., sharing leaflets with patients); the latter particularly so for community pharmacy interventions. These findings suggest that intervention designers believe that increasing knowledge and motivation among all target groups is key to decreasing inappropriate antibiotic consumption.
Psychological capability was targeted in all groups, delivered largely through ‘instruction on how to perform the behavior. Reflective motivation and psychological capability were targeted in patients and prescribers using the BCT ‘information about health consequences’. Interventions targeting patients and prescribers through ‘beliefs about consequences’ (e.g., NHS England’s Patient Safety Alert [47], Public Health England’s Keep Antibiotics Working campaign [48]) could have drawn on a much wider range of techniques. For example, BCT ‘information about emotional consequences’ (e.g., the anxiety of becoming ill knowing antibiotics would not be effective), or BCT ‘anticipated regret’ (e.g., the degree of regret prescribers may feel in the future if they do not modify their antibiotic prescribing), or by employing incentives or rewards. Provider and commissioner interventions focused more on ‘Feedback on behavior’, for example interventions giving feedback on prescribing and local antimicrobial resistance rates (e.g., NHS England Quality Premium: 2016/17 Guidance for CCGs [49], Public Health England Fingertips platform [50] and PrescQIPP Antimicrobial Stewardship [51]) with the aim of facilitating a change in behavioral regulation (the mental skills to carry out the mental tasks required to perform the behavior).
Physical opportunity was another commonly targeted domain in interventions aimed at all target groups. The most frequently used technique was ‘adding objects to the environment’ (i.e., provision of information leaflets). Many other techniques appropriate for targeting this domain were not used, for example, avoiding/reducing exposure to cues for the behavior which could, e.g., involve diverting patients with self-limiting infections to the pharmacy via appointment booking lines as suggested in Pinder et al. [19].
With the exception of community pharmacy, Interventions were identified across all settings, which targeted social opportunity through social comparison with peers (e.g., UK Chief Medical Officer letter to high prescribers of antibiotics [52]) and practical social support (e.g., Self Care Forum: Self Care Week [53]).
We identified few (8/39) interventions which aimed to change behavior by targeting ‘automatic motivation’, such as routines and habits (e.g., encouraging routine feedback where antibiotics are not prescribed according to guidelines), emotional drives (e.g., addressing concerns about the negative consequences of not prescribing antibiotics), and reinforcement (e.g., incentivizing participation in AMS training), which can be powerful influences on behavior. Designing new interventions and refining existing interventions may merit considering targeting these influences.

6. Limitations

There are three key limitations to this study. First, the interventions included in this study are implemented at a national level. The devolution of responsibility to local health and public health teams means the many interventions which were designed and implemented locally are not included. Secondly, we did not establish the extent to which included interventions were effective in changing behavior nor the extent to which they are implemented. Thirdly, whilst we obtained most of the materials and documents related to each included intervention, we were unable to access all materials.

7. Future Research Directions

The mechanisms of action of interventions were determined by applying available resources which link COM-B and TDF to intervention content (intervention types and BCTs). This process established how interventions are likely to have an effect on behavior. Future intervention design and refinement would be supported by establishing the barriers and facilitators to the behaviors identified in this study and then comparing them with intervention content to determine the extent to which intervention content appropriately targets identified barriers and facilitators. Establishing the extent to which interventions are effective will support interpretation of these findings. Establishing which behaviors are key in influencing AMR will support the prioritization of intervention design and refinement.
Intervention design and refinement would be aided with the provision of accessible guidance on processes such as that described above to support intervention designers with a range of expertise in behavior change.

8. Conclusions

Although changing behaviors alone cannot fully halt the AMR problem, patient and physician behaviors in primary care offer a unique opportunity for AMR interventions. Targeting behaviors amenable to change using effective, evidence-based BCTs, may offer new cost-effective methods to reduce antibiotic prescribing and thus halt the rise in the number of patients suffering from infections due to AMR. This study highlights the need to review existing interventions to ensure they are optimized to influence AMR-related behaviors. Any gaps identified in current provision should be considered for future intervention design and refinement, ensuring these are aligned to work within the NHS’s changing provision of primary care.

9. Declarations

9.1. Ethics Approval and Consent to Participate

Not applicable.

9.2. Consent for Publication

Not applicable.

9.3. Availability of Data and Material

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Supplementary Materials

The following are available online at https://www.mdpi.com/2079-6382/9/8/512/s1, Table S1: Labels, definitions and examples of COM-B and Theoretical Domains Framework; Table S2: Behaviour Change Wheel labels, definitions and examples; Table S3: Source materials for behavior; Table S4: Summary of intervention content, mechanism of action and target behaviour.

Author Contributions

Conceptualization, T.C. and A.S.; formal analysis, L.A. and A.S.; investigation, L.A., P.B., N.H., V.d.L.M., M.G.-I. and A.S.; methodology, L.A., T.C. and A.S.; supervision, T.C.; writing—original draft, L.A. and A.S.; writing—review & editing, T.C., P.B., D.A.-O., E.B., N.H., V.d.L.M, M.G.-I., S.H. and C.M. All authors have read and agreed to the published version of the manuscript.

Funding

This project was funded by Public Health England.

Conflicts of Interest

T.C., P.B., D.A.-O., S.H. and A.S. are employed by project funders, Public Health England.

Appendix A

Table A1. Summary of intervention, target group, behavior, mechanism of action, and intervention content.
Table A1. Summary of intervention, target group, behavior, mechanism of action, and intervention content.
Mechanism of ActionIntervention Content
InterventionTarget GroupBehaviorCOM-BTDFIntervention TypeBCTPolicy Option
Public Health England Antibiotic Guardian [37]Patients
1.
Self-care and/or obtain pharmacy advice for signs and symptoms of self-limiting respiratory tract infections prior to, or instead of, a primary care consultation.
Psychological capabilityKnowledgeEducationCommitmentService provision
Prescribers
2.
Do not request antibiotics at primary care consultations for symptoms of self-limiting RTIs.
Reflective motivationSocial influencesPersuasionAdding objects to the environmentCommunication and marketing
Community pharmacists and pharmacy staff
3.
Take antibiotics as prescribed (do not save for later use or share with others) by a suitably qualified HCP.
Automatic motivationBeliefs about consequencesTrainingCredible source
Providers
4.
Return unwanted antibiotics to the pharmacy.
Physical opportunityIntentionIncentivizationSocial reward
Commissioners
5.
Prescribe an antibiotic only when there is likely to be clear clinical benefit (using fever PAIN or CENTOR for sore throat).
OR Do not issue an immediate prescription for an antimicrobial to a patient who is likely to have a self-limiting condition.
Social opportunityEnvironmental context and resourcesEnablementInstruction on how to perform the behavior
6.
Give alternative, non-antibiotic self-care advice, where appropriate.
Memory attention and decision makingModelingPrompts/cues
7.
Use/share written self-care resources/leaflets when issuing self-care advice for symptoms of self-limiting RTIs.
Emotion Information about health consequences
8.
Provide safety netting advice whether or not the patient has been prescribed antibiotics (e.g., what to do if condition gets worse or side effects of medication).
Social professional role and identitySalience of consequences
9.
Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
Demonstration of the behavior
10.
Provide self-care advice for patients with symptoms of self-limiting RTIs, instead of, following or prior to referral to a primary care clinician, giving safety netting advice where appropriate.
Identification of self as role model
11.
Use/share written resources with the public when providing self-care advice for self-limiting RTIs.
12.
When giving an antibiotic prescription for a self-limiting RTI, inform the patients of the dose and duration or to take their antibiotics exactly as prescribed.
13.
Check that antibiotic prescriptions comply with local guidance and query with the prescriber for those that do not.
14.
Accept and dispose appropriately of returned antibiotics.
15.
Commission, develop or implement interventions (e.g., guidance, services, programs, or campaigns) to support AMS/tackle AMR
16.
Commission, develop or implement interventions (e.g., guidance, services, programs, or campaigns) to support AMS/tackle AMR.
17.
Monitor antibiotic prescribing in relation to local and national resistance patterns or targets.
18.
Promote current national guidelines, or promote/develop local guidelines on antimicrobial prescribing among all prescribers, providing updates if the guidelines change.
UK Department of Health and Public Health England Antimicrobial Prescribing and Stewardship Competencies [41]Prescribers
1.
Follow/adhere to local antibiotic formulary—general behaviors.
Psychological capabilityKnowledgeEducationInformation about health consequencesGuidelines
Providers
2.
Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat).
OR Do not issue an immediate prescription for an antimicrobial to a patient who is likely to have a self-limiting condition.
Behavioral regulationTrainingSelf-monitoring of outcomes of behavior
Commissioners
3.
Give alternative, non-antibiotic self-care advice, where appropriate.
Social support (practical)
4.
Use/share written self-care resources/leaflets when issuing self-care advice for symptoms of self-limiting RTIs.
Instruction on how to perform the behavior
5.
When an antibiotic is indicated prescribe the narrowest spectrum antibiotic possible, for the right duration, at the right dose.
6.
Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
7.
Explain the prescribing decision to the patient, including where appropriate, the benefits and harms of antibiotics.
8.
Document, in patients records, clinical diagnosis (including symptoms) if prescribing an immediate or back up antimicrobial and/or giving self-care advice.
9.
Provide education and training in prudent antimicrobial use/AMR (using the
antimicrobial resistance and stewardship competencies as a framework).
10.
Monitor antibiotic prescribing in relation to local and national resistance patterns or targets.
The Health and Social Care Act (HSCA) 2008. Code of Practice on the prevention and control of infections and related guidance [54]Providers
1.
Provide education and training in prudent antimicrobial use/AMR (using the antimicrobial resistance and stewardship competencies as a framework).
Psychological capabilityKnowledgeTrainingInstruction on how to perform the behaviorRegulation
Commissioners
2.
Commission, develop or implement interventions (e.g., guidance, services, programs, or campaigns) to support AMS/tackle AMR.
3.
Monitor antibiotic prescribing in relation to local and national resistance patterns or targets.
4.
Promote current national guidelines, or promote/develop local guidelines on antimicrobial prescribing among all prescribers, providing updates if the guidelines change.
5.
Promote current national guidelines, or promote/develop local guidelines on antimicrobial prescribing among all prescribers, providing updates if the guidelines change.
6.
Providers have a formulary in place for antibiotic prescribing
NICE Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use [NG15] [17]Providers
1.
Follow/adhere to local antibiotic formulary—general behaviors.
Psychological capabilitySkillsTrainingInstruction on how to perform the behaviorGuidelines
Commissioners
2.
Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat).
OR Do not issue an immediate prescription for an antimicrobial to a patient who is likely to have a self-limiting condition.
Behavioral regulationEducationSelf-monitoring of outcomes of behavior
Prescribers
3.
Give alternative, non-antibiotic self-care advice, where appropriate.
Community pharmacists and pharmacy staff
4.
Provide safety netting advice whether or not the patient has been prescribed antibiotics (e.g., what to do if condition gets worse or side effects of medication).
5.
Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
6.
Explain the prescribing decision to the patient, including where appropriate, the benefits and harms of antibiotics.
7.
Document, in patients records, clinical diagnosis (including symptoms) if prescribing an immediate or back up antimicrobial and/or giving self-care advice.
8.
Undertake POCT in patients 18–65 years old presenting with acute cough/bronchitis in whom antibiotics are being considered.
9.
Check that antibiotic prescriptions comply with local guidance and query with the prescriber for those that do not.
10.
Provide education and training in prudent antimicrobial use/AMR (using the
antimicrobial resistance and stewardship competencies as a framework).
11.
Commission, develop or implement interventions (e.g., guidance, services, programs, or campaigns) to support AMS/tackle AMR.
12.
Monitor antibiotic prescribing in relation to local and national resistance patterns or targets.
13.
Promote current national guidelines, or promote/develop local guidelines on antimicrobial prescribing among all prescribers, providing updates if the guidelines change.
14.
Promote current national guidelines, or promote/develop local guidelines on antimicrobial prescribing among all prescribers, providing updates if the guidelines change.
15.
Provide feedback to prescribers on patient safety incidents related to antimicrobial use, including hospital admissions for potentially avoidable life-threatening infections, infections with Clostridium difficile or adverse drug reactions, such as anaphylaxis.
16.
Providers have a formulary in place for antibiotic prescribing.
NICE Infection Prevention and Control [QS61] [27]Patients
1.
Do not request antibiotics at primary care consultations for symptoms of self-limiting RTIs.
Psychological capabilityKnowledgeEducationInstruction on how to perform the behaviorGuidelines
Prescribers
2.
Follow/adhere to local antibiotic formulary prescribers.
SkillsTrainingSelf-monitoring of the behavior
Providers
3.
Prescribe an antibiotic only when there is clear clinical benefit.
Behavioral regulationEnablementAction planning
Commissioners
4.
When an antibiotic is indicated prescribe the narrowest spectrum antibiotic possible, for the right duration, at the right dose.
Information about health consequences
5.
Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
6.
Limit prescribing over the telephone to exceptional cases for self-limiting RTIs.
7.
Provide education and training.
8.
Commission, develop or implement interventions to support AMS.
9.
Monitor antibiotic prescribing in relation to local and national resistance patterns or targets.
10.
Promote current national guidelines, or promote/develop local guidelines on antimicrobial prescribing among all prescribers, providing updates if the guidelines change.
11.
Provide regular feedback on antimicrobials prescribing.
12.
Providers have a formulary in place for prescribing.
13.
Commissioners seek evidence/providers make evidence available for adherence to local or national guidance for antibiotic prescribing.
NHS England Quality Premium: 2016/17 Guidance for CCGs [49]Providers
1.
Monitor antibiotic prescribing in relation to local and national resistance patterns or targets.
Automatic motivationReinforcementIncentivizationMaterial rewardFiscal measures
Commissioners
2.
Reduce antibiotic prescribing/antimicrobial resistance—general behaviors.
Psychological capabilityBehavioral regulationEducationFeedback on the behavior
NHS England Patient Safety Alert—addressing antimicrobial resistance through implementation of an antimicrobial stewardship program [47]Providers
1.
Commission, develop or implement interventions (e.g., guidance, services, programs, or campaigns) to support AMS/tackle AMR.
Physical opportunityEnvironmental context and resourcesEnablementAdding objects to the environmentCommunication/marketing
Commissioners Reflective motivationBeliefs about consequencesEducationInformation about health consequences
TARGET Antibiotics Toolkit (Treat Antibiotics Responsibly, Guidance, Education, Tools) [38]Patients
1.
Self-care and/or obtain pharmacy advice for signs and symptoms of self-limiting respiratory tract infections prior to, or instead of, a primary care consultation.
Psychological capabilityBehavioral regulationEducationAction planningService provision
Prescribers
2.
Do not request antibiotics at primary care consultations for symptoms of self-limiting RTIs.
Reflective motivationBeliefs about consequencesEnablementAdding objects to the environmentGuidelines
Community pharmacists and pharmacy staff
3.
Use back-up prescriptions as directed by a suitably qualified healthcare professional (HCP).
Automatic motivationSkillsIncentivizationDemonstration of the behaviorCommunication and marketing
Providers
4.
Take antibiotics as prescribed (do not save for later use or share with others) by a suitably qualified HCP.
Physical opportunityKnowledgeModelingFeedback on the behavior
Commissioners
5.
Return unwanted antibiotics to the pharmacy.
Social opportunityEnvironmental context and resourcesPersuasionIdentification of self as role model
6.
Follow/adhere to local antibiotic formulary—general behaviors
IntentionTrainingInformation about health consequences
7.
Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat). OR Do not issue an immediate prescription for an antimicrobial to a patient who is likely to have a self-limiting condition.
Reinforcement Information about social environmental consequences
8.
Give alternative, non-antibiotic self-care advice, where appropriate.
Social influences Instruction on how to perform the behavior
9.
Use/share written self-care resources/leaflets when issuing self-care advice for symptoms of self-limiting RTIs.
Social professional role and identity Reward (non material)
10.
Provide safety netting advice whether or not the patient has been prescribed antibiotics (e.g., what to do if condition gets worse or side effects of medication).
Self-monitoring of the behavior
11.
When an antibiotic is indicated prescribe the narrowest spectrum antibiotic possible, for the right duration, at the right dose.
Credible source
12.
Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
13.
Explain the prescribing decision to the patient, including where appropriate, the benefits and harms of antibiotics.
14.
Document, in patients records, clinical diagnosis (including symptoms) if prescribing an immediate or back up antimicrobial and/or giving self-care advice.
15.
Undertake POCT in patients 18–65 years old presenting with acute cough/bronchitis in whom antibiotics are being considered.
16.
Provide self-care advice for patients with symptoms of self-limiting RTIs, instead of, following or prior to referral to a primary care clinician, giving safety netting advice where appropriate.
17.
Use/share written resources with the public when providing self-care advice for self-limiting RTIs.
18.
Provide education and training in prudent antimicrobial use/AMR (using the antimicrobial resistance and stewardship competencies as a framework).
19.
Commission, develop or implement interventions (e.g., guidance, services, programs, or campaigns) to support AMS/tackle AMR.
20.
Commission, develop or implement interventions (e.g., guidance, services, programs, or campaigns) to support AMS/tackle AMR.
21.
Monitor antibiotic prescribing in relation to local and national resistance patterns or targets.
22.
Promote current national guidelines, or promote/develop local guidelines on antimicrobial prescribing among all prescribers, providing updates if the guidelines change.
23.
Promote current national guidelines, or promote/develop local guidelines on antimicrobial prescribing among all prescribers, providing updates if the guidelines change.
24.
Providers have a formulary in place for antibiotic prescribing.
25.
Commissioners seek evidence/providers make evidence available for adherence to local or national guidance for antibiotic prescribing.
26.
Commissioners ensure information and resources are available for healthcare professionals to use during consultations with people seeking advice about managing self-limiting RTIs.
27.
Reduce antibiotic prescribing/antimicrobial resistance—general behaviors.
Treat Yourself Better [40]Patients
  • Self-care and/or obtain pharmacy advice for signs and symptoms of self-limiting respiratory tract infections prior to, or instead of, a primary care consultation.
Reflective motivationIntentionPersuasionCredible sourceCommunication and marketing
Social opportunityKnowledgeEducationInformation about health consequences
Psychological capabilitySkillsTrainingInstruction on how to perform the behavior
Social influencesEnablementSocial comparison
Beliefs about consequences Information about social and environmental consequences
UK Chief Medical Officer letter to high prescribers of antibiotics [52]Prescribers
1.
Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat).
Psychological capabilityBehavioral regulationPersuasionSocial comparisonCommunication/marketing
2.
Give alternative, non-antibiotic self-care advice, where appropriate. Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
Reflective motivationIntentionTrainingCredible source
3.
Use/share written self-care resources/leaflets when issuing self-care advice for symptoms of self-limiting RTIs.
Physical opportunityKnowledgeEducationInstruction on how to perform the behavior
4.
Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
Environmental context and resourcesEnablementAdding objects to the environment
Beliefs about consequences Behavioral substitution
Optimism Feedback on the behavior
Information about health consequences
Public Health England Fingertips platform [50]Commissioners
1.
Monitor antibiotic prescribing in relation to local and national resistance patterns or targets.
Psychological capabilityBehavioral regulationEducationFeedback on the behaviorService provision
Providers
2.
Reduce antibiotic prescribing/antimicrobial resistance—general behaviors.
Reflective motivationIntentionEnablementFeedback on outcome(s) of behavior
Knowledge Social comparison
Information about health consequences
PrescQIPP Antimicrobial Stewardship [51]Prescribers
1.
Use/share written self-care resources/leaflets when issuing self-care advice for symptoms of self-limiting RTIs.
Physical opportunityEnvironmental context and resourcesEnablementSocial support (practical)Service provision
Providers
2.
Commission, develop or implement interventions (e.g., guidance, services, programs, or campaigns) to support self-care.
Reflective motivationBeliefs about consequencesEducationInformation about social and environmental consequences
Commissioners
3.
Monitor antibiotic prescribing in relation to local and national resistance patterns or targets.
Psychological capabilitySkillsTrainingInstruction on how to perform the behavior
Social opportunityBehavioral regulationPersuasionPros and cons
Social influences Feedback on the behavior
Feedback on outcome(s) of behavior
Social comparison
UK Five Year Antimicrobial Resistance Strategy 2013 to 2018 [15]Prescribers
1.
Follow/adhere to local antibiotic formulary—general behaviors.
Reflective motivationBeliefs about consequencesEducationInformation about health consequencesGuidelines
Providers
2.
Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat).
Psychological capabilityKnowledgeTrainingInstruction on how to perform the behavior
Commissioners
3.
When an antibiotic is indicated prescribe the narrowest spectrum antibiotic possible, for the right duration, at the right dose.
Physical opportunityBehavioral regulationEnablementAdding objects to the environment
4.
Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
Environmental context and resourcesCoercionFuture punishment
5.
Explain the prescribing decision to the patient, including where appropriate, the benefits and harms of antibiotics.
OptimismPersuasionIdentification of self as role model
6.
Undertake POCT in patients 18–65 years old presenting with acute cough/bronchitis in whom antibiotics are being considered.
Social professional role and identity
7.
Provide education and training in prudent antimicrobial use/AMR (using the
antimicrobial resistance and stewardship competencies as a framework).
8.
Commission, develop or implement interventions (e.g., guidance, services, programs, or campaigns) to support AMS/tackle AMR
9.
Commissioners seek evidence/providers make evidence available for adherence to local or national guidance for antibiotic prescribing.
NHS website advice on common cold [55]Patients
1.
Self-care and/or obtain pharmacy advice for signs and symptoms of self-limiting respiratory tract infections prior to, or instead of, a primary care consultation.
Psychological capabilityKnowledgeTrainingInformation about health consequencesService provision
2.
Do not request antibiotics at primary care consultations for symptoms of self-limiting RTIs.
Reflective motivationIntentionEducationInstruction on how to perform the behavior
PersuasionCredible source
NICE Antimicrobial stewardship: changing risk-related behaviors in the general population [NG63] [23]Prescribers
1.
Give alternative, non-antibiotic self-care advice, where appropriate.
Psychological capabilityKnowledgeEducationInstruction on how to perform the behaviorGuidelines
Community pharmacists and pharmacy staff
2.
Use/share written self-care resources/leaflets when issuing self-care advice for symptoms of self-limiting RTIs.
Social opportunitySocial influencesTrainingSocial support practical
Providers
3.
Provide safety netting advice whether or not the patient has been prescribed antibiotics (e.g., what to do if condition gets worse or side effects of medication).
Behavioral regulationEnablementSelf-monitoring of behavior
Commissioners
4.
Explain the prescribing decision to the patient, including where appropriate, the benefits and harms of antibiotics.
Action planning
5.
Provide self-care advice for patients with symptoms of self-limiting RTIs, instead of, following or prior to referral to a primary care clinician, giving safety netting advice where appropriate.
Feedback on outcome(s) of behavior
6.
Use/share written resources with the public when providing self-care advice for self-limiting RTIs.
7.
Commission, develop or implement interventions (e.g., guidance, services, programs, or campaigns) to support AMS/tackle AMR.
8.
Commission, develop or implement interventions (e.g., guidance, services, programs, or campaigns) to support self-care.
9.
Promote current national guidelines, or promote/develop local guidelines on antimicrobial prescribing among all prescribers, providing updates if the guidelines change.
10.
Commissioners ensure information and resources are available for healthcare professionals to use during consultations with people seeking advice about managing self-limiting RTIs.
11.
Reduce antibiotic prescribing/antimicrobial resistance—general behaviors.
Center for Pharmacy Postgraduate Education distance course: Antibacterial resistance—a global threat to public health: the role of the pharmacy team [56]Community pharmacists and pharmacy staff
1.
Provide self-care advice for patients with symptoms of self-limiting RTIs, instead of, following or prior to referral to a primary care clinician, giving safety netting advice where appropriate.
Psychological capabilitySkillsTrainingInstruction on how to perform the behaviorGuidelines
Prescribers
2.
Use/share written resources with the public when providing self-care advice for self-limiting RTIs.
Behavioral practice/ rehearsal
3.
When giving an antibiotic prescription for a self-limiting RTI, inform the patients of the dose and duration or to take their antibiotics exactly as prescribed.
4.
Check that antibiotic prescriptions comply with local guidance and query with the prescriber for those that do not.
5.
Accept and dispose appropriately of returned antibiotics.
6.
Follow/adhere to local antibiotic formulary—general behaviors.
7.
Prescribe an antibiotic only when there is clear clinical benefit.
8.
Use/share written self-care resources/leaflets when issuing self-care advice for symptoms of self-limiting RTIs.
9.
When an antibiotic is indicated prescribe the narrowest spectrum antibiotic possible, for the right duration, at the right dose.
10.
Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
11.
Limit prescribing over the telephone to exceptional cases for self-limiting RTIs.
UK Clinical Pharmacy Association/Royal Pharmaceutical Society—professional practice curriculum [57]Prescribers
  • Follow/adhere to local antibiotic formulary–general behaviors.
Psychological capabilityKnowledgeTrainingInstruction on how to perform the behaviorGuidelines
FeverPAIN [58]Prescribers
  • Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat).
    OR Do not issue an immediate prescription for an antimicrobial to a patient who is likely to have a self-limiting condition.
Psychological capabilityKnowledgeEnablementAdding objects to the environmentService provision
Reflective motivationBeliefs about consequencesEducationInformation about health consequences
Public health England Managing Common Infections Guidance [28]Prescribers
1.
Follow/adhere to local antibiotic formulary—general behaviors.
Reflective motivationIntentionTrainingInstruction on how to perform the behaviorGuidelines
2.
Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat).
KnowledgePersuasionCredible source
3.
When an antibiotic is indicated prescribe the narrowest spectrum antibiotic possible, for the right duration, at the right dose.
4.
Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
5.
Undertake POCT in patients 18–65 years old presenting with acute cough/bronchitis in whom antibiotics are being considered.
6.
Limit prescribing over the telephone to exceptional cases for self-limiting RTIs.
NICE Respiratory tract infections (self-limiting): prescribing antibiotics [CG69] [59]Patients
1.
Self-care and/or obtain pharmacy advice for signs and symptoms of self-limiting respiratory tract infections prior to, or instead of, a primary care consultation.
Psychological capabilityKnowledgeTrainingInstruction on how to perform the behaviorGuidelines
Prescribers
2.
Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat).
OR Do not issue an immediate prescription for an antimicrobial to a patient who is likely to have a self-limiting condition.
SkillsEnablementSocial support practical
3.
Give alternative, non-antibiotic self-care advice, where appropriate.
4.
Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
NICE Antimicrobial Stewardship [QS121] [29]Prescribers
1.
Follow/adhere to local antibiotic formulary—general behaviors.
Physical opportunityBehavioral regulationEducationFeedback on behaviorGuidelines
Providers
2.
Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat).
Psychological capabilityBeliefs about consequencesEnablementSelf-monitoring of behavior
Commissioners
3.
Give alternative, non-antibiotic self-care advice, where appropriate. Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
Reflective motivationEnvironmental context and resourcesTrainingGoal setting (behavior)
4.
Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
GoalsEnvironmental restructuringInformation about health consequences
5.
Explain the prescribing decision to the patient, including where appropriate, the benefits and harms of antibiotics.
KnowledgePersuasionInstruction on how to perform the behavior
6.
Document, in patients records, clinical diagnosis (including symptoms) if prescribing an immediate or back up antimicrobial and/or giving self-care advice.
Restructuring the physical environment
7.
Commission, develop or implement interventions (e.g., guidance, services, programs, or campaigns) to support AMS/tackle AMR
Action planning
8.
Commission, develop or implement interventions (e.g., guidance, services, programs, or campaigns) to support self-care.
9.
Monitor antibiotic prescribing in relation to local and national resistance patterns or targets.
10.
Promote current national guidelines, or promote/develop local guidelines on antimicrobial prescribing among all prescribers, providing updates if the guidelines change.
11.
Commissioners seek evidence/providers make evidence available for adherence to local or national guidance for antibiotic prescribing.
12.
Reduce antibiotic prescribing/antimicrobial resistance—general behaviors.
Self Care Forum: Factsheet 7 (Cough in Adults); Factsheet 12 (Common Cold) [60]Patients
1.
Self-care and/or obtain pharmacy advice for signs and symptoms of self-limiting respiratory tract infections prior to, or instead of, a primary care consultation.
Psychological capabilitySkillsTrainingInstruction on how to perform the behaviorService provision
2.
Do not request antibiotics at primary care consultations for symptoms of self-limiting RTIs.
KnowledgeEducationInformation about health consequences
Managing Acute Respiratory Tract Infections (MARTI) e-learning [45]Prescribers
3.
Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat).
Automatic motivationReinforcementCoercionAction planning
4.
Give alternative, non-antibiotic self-care advice, where appropriate.
Reflective motivationKnowledgeEducationCredible source
5.
Provide safety netting advice whether or not the patient has been prescribed antibiotics (e.g., what to do if condition gets worse or side effects of medication).
Physical opportunitySocial professional role and identityEnablementDemonstration of the behavior
6.
Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
Psychological capabilityBeliefs about consequencesIncentivizationFeedback on outcome(s) of behavior
7.
Use/share written self-care resources/leaflets when issuing self-care advice for symptoms of self-limiting RTIs.
SkillsPersuasionFraming/reframing
8.
When an antibiotic is indicated prescribe the narrowest spectrum antibiotic possible, for the right duration, at the right dose.
Environmental context and resourcesTrainingFuture punishment
9.
Explain the prescribing decision to the patient, including where appropriate, the benefits and harms of antibiotics.
Identification of self as role model
10.
Document, in patients records, clinical diagnosis (including symptoms) if prescribing an immediate or back up antimicrobial and/or giving self-care advice.
Information about health consequences
Information about social environmental consequences
Instruction on how to perform the behavior
Non-specific reward
Problem solving
Salience of consequences
Self-monitoring of outcome(s) of the behavior
Stemming the Tide of Antibiotic Resistance (STAR) e-learning [44]Prescribers
1.
Follow/adhere to local antibiotic formulary—general behaviors.
Psychological capabilitySkillsTrainingDemonstration of the behaviorService provision
2.
Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat).
Reflective motivationIntentionPersuasionCredible source
3.
Explain the prescribing decision to the patient, including where appropriate, the benefits and harms of antibiotics.
Social opportunityBeliefs about consequencesModelingInformation about health consequences
Automatic motivationSocial influencesIncentivizationBehavioral practice/rehearsal
Reinforcement Instruction on how to perform the behavior
Information about social and environmental consequences
Non-specific reward
OpenPrescribing.net [61]Providers
  • Monitor antibiotic prescribing in relation to local and national resistance patterns or targets.
Psychological capabilityKnowledgeEducationFeedback on the behaviorService provision
Commissioners EnablementFeedback on the outcome of behavior
Adding objects to the environment
CENTOR [62]Prescribers
1.
Follow/adhere to local antibiotic formulary—general behaviors
Psychological capabilityKnowledgeTrainingInstruction on how to perform the behaviorService provision
2.
Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat).
3.
Document, in patients records, clinical diagnosis (including symptoms) if prescribing an immediate or back up antimicrobial and/or giving self-care advice.
4.
Undertake POCT in patients 18–65 years old presenting with acute cough/bronchitis in whom antibiotics are being considered.
Health Education England ‘Antimicrobial Resistance: A Guide for GPs’ [63]Prescribers
1.
Follow/adhere to local antibiotic formulary—general behaviors.
Psychological capabilityKnowledgeEducationInformation about health consequencesCommunication and marketing
2.
Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat).
OR Do not issue an immediate prescription for an antimicrobial to a patient who is likely to have a self-limiting condition.
Reflective motivationIntentionEnablementSocial support (practical)
3.
Give alternative, non-antibiotic self-care advice, where appropriate.
Automatic motivationEmotionPersuasionCredible source
4.
Use/share written self-care resources/leaflets when issuing self-care advice for symptoms of self-limiting RTIs.
Environmental context and resourcesTrainingAdding objects to the environment
5.
Explain the prescribing decision to the patient, including where appropriate, the benefits and harms of antibiotics.
SkillsCoercionFuture punishment
Social professional role and identity Identification of self as role model
Instruction on how to perform the behavior
Public Health England Keep Antibiotics Working campaign [48]Patients
1.
Self-care and/or obtain pharmacy advice for signs and symptoms of self-limiting respiratory tract infections prior to, or instead of, a primary care consultation.
Psychological capabilityKnowledgeEducationCredible sourceCommunication and marketing
Providers
2.
Do not request antibiotics at primary care consultations for symptoms of self-limiting RTIs.
Reflective motivationBeliefs about consequencesTrainingInformation about health consequences
Commissioners
3.
Commission, develop or implement interventions (e.g., guidance, services, programs, or campaigns) to support AMS/tackle AMR.
Automatic motivationEmotionEnablementInformation about social and environmental consequences
Physical opportunityEnvironmental context and resourcesPersuasionInstruction on how to perform the behavior
Intention Social support (practical)
NICE Sinusitis (acute): antimicrobial prescribing [NG79] [24]Patients
1.
Self-care and/or obtain pharmacy advice for signs and symptoms of self-limiting respiratory tract infections prior to, or instead of, a primary care consultation.
Psychological capabilitySkillsTrainingInstruction on how to perform the behaviorGuidelines
Prescribers
2.
Do not request antibiotics at primary care consultations for symptoms of self-limiting RTIs.
Physical capabilityKnowledgeEducationInformation about health consequences
3.
Use back-up prescriptions as directed by a suitably qualified healthcare professional (HCP).
Reflective motivationMemory attention and decision makingEnablementAction planning
4.
Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat).
OR Do not issue an immediate prescription for an antimicrobial to a patient who is likely to have a self-limiting condition.
Beliefs about consequences Pharmacological support
5.
Give alternative, non-antibiotic self-care advice, where appropriate.
6.
Provide safety netting advice.
7.
When an antibiotic is indicated prescribe the narrowest spectrum antibiotic possible, for the right duration, at the right dose.
8.
Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
NICE Sore throat (acute): antimicrobial prescribing [NG84] [26]Prescribers
1.
Follow/adhere to local antibiotic formulary—general behaviors
Psychological capabilityKnowledgeTrainingInstruction on how to perform the behaviorGuidelines
2.
Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat).
Memory attention and decision makingEducationInformation about health consequences
3.
Give alternative, non-antibiotic self-care advice, where appropriate. Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
EnablementAction planning
4.
Provide safety netting advice
5.
When an antibiotic is indicated prescribe the narrowest spectrum antibiotic possible, for the right duration, at the right dose.
6.
Explain the prescribing decision to the patient, including where appropriate, the benefits and harms of antibiotics.
7.
Provide ‘delayed/back-up’ antibiotic strategy where appropriate.
Department of Health & Social Care ‘Take Care not Antibiotics’ videos [64]Patients
1.
Self-care and/or obtain pharmacy advice for signs and symptoms of self-limiting respiratory tract infections prior to, or instead of, a primary care consultation.
Psychological capabilityKnowledgeTrainingInstruction on how to perform the behaviorCommunication and marketing
2.
Do not request antibiotics at primary care consultations for symptoms of self-limiting RTIs.
SkillsEducationInformation about health consequences
EnablementAction planning
Patient.info webpages on colds, sore throats, antibiotics, bronchitis and sinusitis [65]Patients
3.
Self-care and/or obtain pharmacy advice for signs and symptoms of self-limiting respiratory tract infections prior to, or instead of, a primary care consultation.
Psychological capabilityKnowledgeEducationInformation about health consequencesService provision
4.
Do not request antibiotics at primary care consultations for symptoms of self-limiting RTIs.
Reflective motivationIntentionTrainingInstruction on how to perform the behavior
5.
Use back-up prescriptions as directed by a suitably qualified healthcare professional (HCP).
6.
Take antibiotics as prescribed (do not save for later use or share with others) by a suitably qualified HCP.
PersuasionCredible source
Health Education England ‘Awareness of Antimicrobial Resistance (AMR) Animation’ [66]Patients
  • Do not request antibiotics at primary care consultations for symptoms of self-limiting RTIs.
Reflective motivationBeliefs about consequencesPersuasionSalience of consequencesCommunication and marketing
Psychological capabilityKnowledgeEducationInformation about health consequences
Identification of self as role model
Self Care Forum: Self Care Week [53]Patients
1.
Self-care and/or obtain pharmacy advice for signs and symptoms of self-limiting respiratory tract infections prior to, or instead of, a primary care consultation.
Psychological capabilityKnowledgeEducationInformation about health consequencesCommunication and marketing
Providers
2.
Do not request antibiotics at primary care consultations for symptoms of self-limiting RTIs.
SkillsTrainingInstruction on how to perform the behavior
Commissioners
3.
Commission, develop or implement interventions (e.g., guidance, services, programs, or campaigns) to support self-care.
Memory attention and decision makingEnablementSocial support (practical)
Prompts/cues
theLearningpharmacy.com [42]Community pharmacists and pharmacy staff
1.
Provide self-care advice for patients with symptoms of self-limiting RTIs, instead of, following or prior to referral to a primary care clinician, giving safety netting advice where appropriate.
Psychological capabilityKnowledgeTrainingInstruction on how to perform the behaviorService provision
2.
Use/share written resources with the public when providing self-care advice for self-limiting RTIs.
Physical opportunityEnvironmental context and resourcesEnablementAdding objects to the environment
3.
Check that antibiotic prescriptions comply with local guidance and query with the prescriber for those that do not.
Skills Behavioral practice/ rehearsal
Public Health England ‘Beat the Bugs’ course [46]Patients
1.
Self-care and/or obtain pharmacy advice for signs and symptoms of self-limiting respiratory tract infections prior to, or instead of, a primary care consultation.
Psychological capabilityKnowledgeEducationSalience of consequencesService provision
2.
Do not request antibiotics at primary care consultations for symptoms of self-limiting RTIs.
Reflective motivationBehavioral regulationEnablementInformation about health consequences
3.
Take antibiotics as prescribed (do not save for later use or share with others) by a suitably qualified HCP.
Automatic motivationBeliefs about consequencesTrainingAction-planning
4.
Return unwanted antibiotics to the pharmacy.
ReinforcementIncentivizationInstruction on how to perform the behavior
SkillsPersuasionBehavioral practice/ rehearsal
Non-specific reward
Royal Pharmaceutical Society: Antimicrobial Stewardship Quick Reference Guide [31]Community pharmacists and pharmacy staff
1.
Provide self-care advice for patients with symptoms of self-limiting RTIs, instead of, following or prior to referral to a primary care clinician, giving safety netting advice where appropriate.
Reflective motivationSocial professional role and identityPersuasionIdentification of self as role modelService provision
2.
When giving an antibiotic prescription for a self-limiting RTI, inform the patients of the dose and duration or to take their antibiotics exactly as prescribed.
Psychological capabilityBeliefs about capabilitiesTrainingFocus on past success
3.
Check that antibiotic prescriptions comply with local guidance and query with the prescriber for those that do not.
Physical opportunityKnowledgeEnablementInstruction on how to perform the behavior
Environmental context and resources Adding objects to the environment
Royal College of Nursing (RCN) and Infection Prevention Society (IPS) Infection Prevention and Control Commissioning Toolkit [43]Providers
1.
Commissioners seek evidence/providers make evidence available for adherence to local or national guidance for antibiotic prescribing.
Psychological capabilityKnowledgeTrainingInstruction on how to perform the behaviorGuidelines
Commissioners
2.
Commission, develop or implement interventions (e.g., guidance, services, programs, or campaigns) to support AMS/tackle AMR.
3.
Monitor antibiotic prescribing in relation to local and national resistance patterns or targets.
4.
Providers have a formulary in place for antibiotic prescribing.
British Society for Antimicrobial Chemotherapy: Antibiotic Action [39]Patients
1.
Self-care and/or obtain pharmacy advice for signs and symptoms of self-limiting respiratory tract infections prior to, or instead of, a primary care consultation.
Psychological capabilityKnowledgeEducationInformation about health consequencesService provision
Prescribers
2.
Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat).
OR Do not issue an immediate prescription for an antimicrobial to a patient who is likely to have a self-limiting condition.
Reflective motivationSocial professional role and identityPersuasionIdentification of self as role model
Community pharmacists and pharmacy staff
3.
Provide self-care advice for patients with symptoms of self-limiting RTIs, instead of, following or prior to referral to a primary care clinician, giving safety netting advice where appropriate.
Physical opportunityEnvironmental context and resourcesEnablementAdding objects to the environment
Providers
4.
Reduce antibiotic prescribing/antimicrobial resistance—general behaviors.
Commissioners
5.
Do not request antibiotics at primary care consultations for symptoms of self-limiting RTIs.
6.
Take antibiotics as prescribed (do not save for later use or share with others) by a suitably qualified HCP.

References

  1. European Centre for Disease Prevention and Control European Medicines Agency. The Bacterial Challenge: Time to React; European Centre for Disease Prevention and Control: Stockholm, Sweden, 2009.
  2. Cassini, A.; Högberg, L.D.; Plachouras, D.; Quattrocchi, A.; Hoxha, A.; Simonsen, G.S.; Colomb-Cotinat, M.; Kretzschmar, M.E.; Devleesschauwer, B.; Cecchini, M.; et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis. Lancet Infect. Dis. 2019, 19, 56–66. [Google Scholar] [CrossRef] [Green Version]
  3. European Commission. A European One Health Action Plan against Antimicrobial Resistance (AMR). 2017. Available online: https://ec.europa.eu/health/amr/sites/amr/files/amr_action_plan_2017_en.pdf (accessed on 9 March 2020).
  4. HM Goverment and Wellcome Trust. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. 2014. Available online: https://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf (accessed on 9 March 2020).
  5. Ad hoc Interagency Coordination Group on Antimicrobial Resistance. No Time to Wait: Securing the Future From Drug-Resistant Infections, in Report to the Secretary-General of the United Nations. 2019. Available online: https://www.who.int/antimicrobial-resistance/interagency-coordination-group/final-report/en/ (accessed on 9 March 2020).
  6. Public Health England. English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Report 2018–2019. Public Health England: London. 2019. Available online: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/843129/English_Surveillance_Programme_for_Antimicrobial_Utilisation_and_Resistance_2019.pdf (accessed on 9 March 2020).
  7. European Centre for Disease Prevention and Control. Antimicrobial Consumption in the EU/EEAAnnual Epidemiological Report for 2018. Stockholm. 2018. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/Antimicrobial-consumption-EU-EEA.pdf (accessed on 9 March 2020).
  8. Michie, S.; Atkins, L.; West, R. The Behaviour Change Wheel—A Guide to Designing Interventions; Silverback Publishing: Great Britain, UK, 2014. [Google Scholar]
  9. Tonkin-Crine, S.; Walker, A.S.; Butler, C.C. Contribution of behavioural science to antibiotic stewardship. BMJ 2015, 350, h3413. Available online: https://www.ncbi.nlm.nih.gov/pubmed/26111947 (accessed on 9 March 2020). [CrossRef] [PubMed]
  10. HM Government & Wellcome Trust. Infection Prevention, Control And Surveillance: Limiting the Development and Spread of Drug Resistance. 2016. Available online: https://amr-review.org/sites/default/files/Health%20infrastructure%20and%20surveillance%20final%20version_LR_NO%20CROPS.pdf (accessed on 9 March 2020).
  11. National Health Service. The Antibiotic Awareness Campaign. 2015. Available online: http://www.nhs.uk/NHSEngland/ARC/Pages/AboutARC.aspx (accessed on 9 March 2020).
  12. European Centre for Disease Prevention and Control. Survey of Healthcare Workers’ Knowledge, Attitudes and Behaviours on Antibiotics, Antibiotic Use and Antibiotic Resistance in the EU/EEA. 2019: Stockholm. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/survey-of-healthcare-workers-knowledge-attitudes-behaviours-on-antibiotics.pdf (accessed on 9 March 2020).
  13. European Commission. Special Eurobarometer 478 Report Antimicrobial Resistance. 2018. Available online: https://ec.europa.eu/commfrontoffice/publicopinion/index.cfm/Survey/getSurveyDetail/instruments/SPECIAL/surveyKy/2190 (accessed on 9 March 2020).
  14. Cals, J.W.; Boumans, D.; Lardinois, R.J.; Gonzales, R.; Hopstaken, R.M.; Butler, C.C.; Dinant, G.J. Public beliefs on antibiotics and respiratory tract infections: An internet-based questionnaire study. Br. J. Gen. Pract. 2007, 57, 942–947. Available online: https://www.ncbi.nlm.nih.gov/pubmed/18252068 (accessed on 9 March 2020). [CrossRef] [Green Version]
  15. Department of Health Department for Environment Food & Rural Affairs. UK Five Year Antimicrobial Resistance Strategy 2013 to 2018. 2013. Available online: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_year_AMR_strategy.pdf (accessed on 9 March 2020).
  16. Goff, D.A.; Kullar, R.; Goldstein, E.J.C.; Gilchrist, M.; Nathwani, D.; Cheng, A.C.; Cairns, K.A.; Escandón-Vargas, K.; Villegas, M.V.; Brink, A.; et al. A global call from five countries to collaborate in antibiotic stewardship: United we succeed, divided we might fail. Lancet Infect. Dis. 2017, 17, e56–e63. Available online: http://www.sciencedirect.com/science/article/pii/S1473309916303863 (accessed on 9 March 2020). [CrossRef] [Green Version]
  17. National Institute for Health and Care Excellence. Antimicrobial Stewardship: Systems and Processes for Effective Antimicrobial Medicine Use (NICE Guideline 15). 2015. Available online: https://www.nice.org.uk/guidance/ng15 (accessed on 9 March 2020).
  18. Charani, E.; Castro-Sanchez, E.; Sevdalis, N.; Kyratsis, Y.; Drumright, L.; Shah, N.; Holmes, A. Understanding the Determinants of Antimicrobial Prescribing Within Hospitals: The Role of “Prescribing Etiquette”. Clin. Infect. Dis. 2013, 57, 188–196. [Google Scholar] [CrossRef]
  19. Pinder, R.; Berry, D.; Sallis, A.; Chadborn, T. Behaviour Change and Antibiotic Prescribing in Healthcare Settings: Literature Review and Behavioural Analysis. 2015. Available online: https://www.researchgate.net/profile/Richard_Pinder/publication/277937879_Behaviour_change_and_antibiotic_prescribing_in_healthcare_settings_Literature_review_and_behavioural_analysis/links/5576c6dc08ae7521586c7c37/Behaviour-change-and-antibiotic-prescribing-in-healthcare-settings-Literature-review-and-behavioural-analysis.pdf (accessed on 9 March 2020).
  20. Michie, S.; van Stralen, M.M.; West, R. The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implement. Sci. 2011, 6, 42. Available online: https://www.ncbi.nlm.nih.gov/pubmed/21513547 (accessed on 9 March 2020). [CrossRef] [PubMed] [Green Version]
  21. McParland, J.L.; Williams, L.; Gozdzielewska, L.; Young, M.; Smith, F.; MacDonald, J.; Langdridge, D.; Davis, M.; Price, L. Flowers, P. What are the ’active ingredients’ of interventions targeting the public’s engagement with antimicrobial resistance and how might they work? Br. J. Health Psychol. 2018, 23, 804–819. [Google Scholar] [CrossRef] [PubMed]
  22. Michie, S.; Richardson, M.; Johnston, M.; Abraham, C.; Francis, J.; Hardeman, W.; Eccles, M.P.; Cane, J.; Wood, C.E. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: Building an international consensus for the reporting of behavior change interventions. Ann. Behav. Med. 2013, 46, 81–95. Available online: https://www.ncbi.nlm.nih.gov/pubmed/23512568 (accessed on 9 March 2020). [CrossRef] [PubMed]
  23. National Institute for Health and Care Excellence. Antimicrobial Stewardship: Changing Risk-Related Behaviours in the General Population (NICE Guideline 63). 2017. Available online: https://www.nice.org.uk/guidance/ng63 (accessed on 9 March 2020).
  24. National Institute for Health and Care Excellence. Sinusitis (acute): Antimicrobial Prescribing (NICE Guideline 79). 2017. Available online: https://www.nice.org.uk/guidance/ng79 (accessed on 9 March 2020).
  25. Public Health England. Antibiotic Awareness Key Messages. 2017. Available online: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/652262/Antibiotic_Awareness_Key_messages_2017.pdf (accessed on 9 March 2020).
  26. National Institute for Health and Care Excellence. Sore Throat (Acute): Antimicrobial Prescribing (NICE Guideline 84). 2018. Available online: https://www.nice.org.uk/guidance/ng84 (accessed on 9 March 2020).
  27. National Institute for Health and care Excellence. Infection prevention and control (Quality standard 61). 2014. Available online: https://www.nice.org.uk/search?q=QS61 (accessed on 9 March 2020).
  28. Public Health England. Management and Treatment of Common Infections: Antibiotic Guidance for Primary Care: For Consultation and Local Adaptation. 2017. Available online: https://www.gov.uk/government/publications/managing-common-infections-guidance-for-primary-care (accessed on 9 March 2020).
  29. National Institute for Health and Care Excellence. Antimicrobial Stewardship (Quality Standard 121). 2016. Available online: https://www.nice.org.uk/guidance/qs121 (accessed on 9 March 2020).
  30. National Institute for Health and care Excellence. Pneumonia in Adults: Diagnosis and Management (Clinical Guideline 191). 2014. Available online: https://www.nice.org.uk/guidance/cg191 (accessed on 9 March 2020).
  31. Royal Pharmaceutical Society. Quick Reference Guide: Antimicrobial Stewardship. 2017. Available online: https://www.rpharms.com/resources/quick-reference-guides/antimicrobial-stewardship-ams-qrg (accessed on 9 March 2020).
  32. Pharmaceutical Services Negotiating Committee. Disposal of Unwanted Medicines. Available online: https://psnc.org.uk/services-commissioning/essential-services/disposal-of-unwanted-medicines/ (accessed on 26 June 2019).
  33. Michie, S.; Johnston, M.; Francis, J.; Hardeman, W.; Eccles, M. From Theory to Intervention: Mapping Theoretically Derived Behavioural Determinants to Behaviour Change Techniques. Appl. Psychol. 2008, 57, 660–680. Available online: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1464-0597.2008.00341.x (accessed on 9 March 2020). [CrossRef]
  34. Cane, J.; Richardson, M.; Johnston, M.; Ladha, R.; Michie, S. From lists of behaviour change techniques (BCTs) to structured hierarchies: Comparison of two methods of developing a hierarchy of BCTs. Br. J. Health Psychol. 2015, 20, 130–150. Available online: https://www.ncbi.nlm.nih.gov/pubmed/24815766 (accessed on 9 March 2020). [CrossRef] [PubMed]
  35. Byrt, T.; Bishop, J.; Carlin, J.B. Bias prevalence and kappa. J. Clin. Epidemiol. 1993, 46, 423–429. [Google Scholar] [CrossRef]
  36. Landis, J.R.; Koch, G.G. The Measurement of Observer Agreement for Categorical Data. Biometrics 1977, 33, 159–174. Available online: http://www.jstor.org/stable/2529310 (accessed on 9 March 2020). [CrossRef] [PubMed] [Green Version]
  37. Public Health England. Antibiotic Guardian. Available online: https://antibioticguardian.com (accessed on 9 March 2020).
  38. TARGET Antibiotics Toolkit (Treat Antibiotics Responsibly, G., Education, Tools). Available online: http://www.rcgp.org.uk/targetantibiotics (accessed on 9 March 2020).
  39. British Society for Antimicrobial Chemotherapy. Antibiotic Action. Available online: http://antibiotic-action.com (accessed on 9 March 2020).
  40. Treat Yourself Better. Available online: http://www.treatyourselfbetter.co.uk (accessed on 9 March 2020).
  41. Department of Health Expert Committee on Antimicrobial Resistance and Healthcare Associated Infection and Public Health England. Antimicrobial Prescribing and Stewardship Competencies. 2013. Available online: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/253094/ARHAIprescrcompetencies__2_.pdf (accessed on 9 March 2020).
  42. Centre for Pharmacy Postgraduate Education. The Learning Pharmacy. Available online: http://www.thelearningpharmacy.com (accessed on 9 March 2020).
  43. Royal College of Nursing (RCN) and Infection Prevention Society (IPS). Infection Prevention and Control Commissioning Toolkit. 2020. Available online: https://www.rcn.org.uk/professional-development/publications/pub-005375#detailTab (accessed on 9 March 2020).
  44. Healthcare CPD. Star: Stemming the Tide of Antibiotic Resistance. Available online: https://www.healthcarecpd.com/course/star-stemming-the-tide-of-antibiotic-resistance (accessed on 21 May 2020).
  45. Royal College of General Pracitioners. Managing Acute Respiratory Tract Infections. Available online: http://elearning.rcgp.org.uk/course/info.php?id=17 (accessed on 21 May 2020).
  46. Public Health England. Beat the Bugs. Available online: https://e-bug.eu/beat-the-bugs/ (accessed on 21 May 2020).
  47. NHS England. Patient Safety Alert—Addressing Antimicrobial Resistance through Implementation of an Antimicrobial Stewardship Programme. 2015. Available online: https://www.england.nhs.uk/2015/08/psa-amr/ (accessed on 9 March 2020).
  48. Public Health England. Keep Antibiotics Working. 2017. Available online: https://campaignresources.phe.gov.uk/resources/campaigns/58-keep-antibiotics-working/Overview (accessed on 9 March 2020).
  49. NHS England. Quality Premium: 2016/17 Guidance for CCGs. 2016. Available online: https://www.england.nhs.uk/ccg-out-tool/qual-prem/ (accessed on 9 March 2020).
  50. Public Health England. Public Health Profiles. 2020. Available online: https://fingertips.phe.org.uk (accessed on 9 March 2020).
  51. PrescQIPP. Antimicrobial Stewardship. Available online: https://www.prescqipp.info/our-resources/webkits/antimicrobial-stewardship/ (accessed on 9 March 2020).
  52. Hallsworth, M.; Chadborn, T.; Sallis, A.; Sanders, M.; Berry, D.; Greaves, F.; Clements, L.; Davies, S.C. Provision of social norm feedback to high prescribers of antibiotics in general practice: A pragmatic national randomised controlled trial. Lancet 2016, 387, 1743–1752. [Google Scholar] [CrossRef] [Green Version]
  53. Self Care Forum. Self Care Week. Available online: http://www.selfcareforum.org/events/self-care-week-resources/ (accessed on 21 May 2020).
  54. Public and International Health Directorate Health Protection and Emergency Response Division, I.D.B. The Health and Social Care Act 2008 Code of Practice of the Prevention and Control of Infections and Related Guidance. 2015. Available online: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/449049/Code_of_practice_280715_acc.pdf (accessed on 9 March 2020).
  55. National Health Service. Common Cold. Available online: https://www.nhs.uk/conditions/common-cold/ (accessed on 9 March 2020).
  56. Centre for Pharmacy Postgraduate Education. Antibacterial Resistance—A Global Threat to Public Health: The Role of the Pharmacy Team. A CPPE distance learning programme. 2014. Available online: https://www.cppe.ac.uk/programmes/l/antibacres-p-01/ (accessed on 9 March 2020).
  57. UKCPA Expert Professional Curriculum for Antimicrobial Pharmacists. Available online: http://bsac.org.uk/ukcpa-expert-professional-curriculum-for-antimicrobial-pharmacists/ (accessed on 21 May 2020).
  58. FeverPAIN. Available online: https://ctu1.phc.ox.ac.uk/feverpain/index.php (accessed on 21 May 2020).
  59. National Institute for Health and Care Excellence. Respiratory Tract Infections (Self-Limiting): Prescribing Antibiotics Clinical Guideline [cg69]. 2008. Available online: https://www.nice.org.uk/guidance/cg69 (accessed on 9 March 2020).
  60. Self Care Forum. Factsheets. Available online: http://www.selfcareforum.org/fact-sheets/fact-sheets-2020/ (accessed on 20 May 2020).
  61. OpenPrescribing.net. EBM DataLab: University of Oxford. 2020. Available online: https://openprescribing.net (accessed on 9 March 2020).
  62. Centor Score (Modified/McIsaac) for Strep Pharyngitis. Available online: https://www.mdcalc.com/centor-score-modified-mcisaac-strep-pharyngitis (accessed on 21 May 2020).
  63. Health Education England. Antimicrobial Resistance: A Guide for GPs. 2016. Available online: https://www.youtube.com/watch?v=PkYQJettZVo (accessed on 9 March 2020).
  64. Department of Health and Social Care. Take Care not Antibiotics. 2011. Available online: https://www.youtube.com/watch?v=8jdLQSUHKsg (accessed on 9 March 2020).
  65. Patient.info. Available online: https://patient.info/ears-nose-throat-mouth (accessed on 9 March 2020).
  66. Health Education England. Awareness of Antimicrobial Resistance (AMR) Animation. 2016. Available online: https://www.youtube.com/watch?v=oMnU6g2djm4 (accessed on 21 May 2020).
  67. Ward, C. Point-of-care C-reactive protein testing to optimise antibiotic use in a primary care urgent care centre setting. BMJ Open Qual. 2018, 7, e000391. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203029/ (accessed on 9 March 2020). [CrossRef] [PubMed] [Green Version]
Figure 1. Frequency of identification of intervention types by target group. Total count will exceed the maximum number of interventions (n = 39) as many interventions were aimed at more than one target group.
Figure 1. Frequency of identification of intervention types by target group. Total count will exceed the maximum number of interventions (n = 39) as many interventions were aimed at more than one target group.
Antibiotics 09 00512 g001
Figure 2. Frequency of identification of policy options, by target group. Total count will exceed the maximum number of interventions (n = 39) as many interventions were aimed at more than one target group.
Figure 2. Frequency of identification of policy options, by target group. Total count will exceed the maximum number of interventions (n = 39) as many interventions were aimed at more than one target group.
Antibiotics 09 00512 g002
Figure 3. Frequency of identification of BCTs, by target group.
Figure 3. Frequency of identification of BCTs, by target group.
Antibiotics 09 00512 g003
Figure 4. Influences (Capability, Opportunity, Motivation–Behavior (COM-B)) on behavior targeted in interventions, by target group.
Figure 4. Influences (Capability, Opportunity, Motivation–Behavior (COM-B)) on behavior targeted in interventions, by target group.
Antibiotics 09 00512 g004
Figure 5. Influences (Theoretical Domains Framework (TDF)) on behavior targeted in interventions, by target group.
Figure 5. Influences (Theoretical Domains Framework (TDF)) on behavior targeted in interventions, by target group.
Antibiotics 09 00512 g005
Table 1. Behaviors related to antibiotic prescribing for respiratory tract infections (RTI) in primary care.
Table 1. Behaviors related to antibiotic prescribing for respiratory tract infections (RTI) in primary care.
Behavior (Number of Behaviors)Number of Interventions Targeting the Behavior
Patients/Public (and or carers) (n = 5)
Self-care and/or obtain pharmacy advice for signs and symptoms of self-limiting respiratory tract infections prior to, or instead of, a primary care consultation.13
Do not request antibiotics at primary care consultations for symptoms of self-limiting RTIs.12
Use back-up prescriptions as directed by a suitably qualified healthcare professional (HCP).3
Take antibiotics as prescribed (do not save for later use or share with others) by a suitably qualified HCP.4
Return unwanted antibiotics to the pharmacy. 3
Primary care prescribers (including non-medical prescribers, such as nurses and pharmacists) n = 11
Follow/adhere to local antibiotic formulary—general behaviors.13
Prescribe an antibiotic only when there is likely to be clear clinical benefit, (using fever PAIN or CENTOR for sore throat). OR Do not issue an immediate prescription for an antimicrobial to a patient who is likely to have a self-limiting condition.19
Give alternative, non-antibiotic self-care advice, where appropriate.12
Use/share written self-care resources/leaflets when issuing self-care advice for symptoms of self-limiting RTIs.9
Provide safety netting advice whether or not the patient has been prescribed antibiotics (e.g., what to do if condition gets worse or side effects of medication).7
When an antibiotic is indicated prescribe the narrowest spectrum antibiotic possible, for the right duration, at the right dose.9
Provide ‘delayed/back-up’ antibiotic strategy where appropriate. 14
Explain the prescribing decision to the patient, including where appropriate, the benefits and harms of antibiotics.10
Document, in patients records, clinical diagnosis (including symptoms) if prescribing an immediate or back up antimicrobial and/or giving self-care advice.6
Undertake POCT in patients 18–65 years old presenting with acute cough/bronchitis in whom antibiotics are being considered.5
Limit prescribing over the telephone to exceptional cases for self-limiting RTIs.3
Community pharmacists and pharmacy staff(n = 5)
Provide self-care advice for patients with symptoms of self-limiting RTIs, instead of, following or prior to referral to a primary care clinician, giving safety netting advice where appropriate.7
Use/share written resources with the public when providing self-care advice for self-limiting RTIs.5
When giving an antibiotic prescription for a self-limiting RTI, inform the patients of the dose and duration or to take their antibiotics exactly as prescribed.3
Check that antibiotic prescriptions comply with local guidance and query with the prescriber for those that do not.5
Accept and dispose appropriately of returned antibiotics.2
Providers and commissioners (n = 11)
Provide education and training in prudent antimicrobial use/AMR (using the antimicrobial resistance and stewardship competencies as a framework).6
Commission, develop, or implement interventions (e.g., guidance, services, programs, or campaigns) to support AMS/tackle AMR.11
Commission, develop, or implement interventions (e.g., guidance, services, programs, or campaigns) to support self-care.6
Monitor antibiotic prescribing in relation to local and national resistance patterns or targets.12
Promote current national guidelines, or promote/develop local guidelines on antimicrobial prescribing among all prescribers, providing updates if the guidelines change.6
Provide regular feedback on antimicrobial prescribing and resistance indicators at prescriber, team, and organization level benchmarked against local or national antimicrobial prescribing/resistance rates.5
Provide feedback to prescribers on patient safety incidents related to antimicrobial use, including hospital admissions for potentially avoidable life-threatening infections, infections with Clostridium difficile or adverse drug reactions, such as anaphylaxis.1
Providers have a formulary in place for antibiotic prescribing. *5
Commissioners seek evidence/providers make evidence available for adherence to local or national guidance for antibiotic prescribing. **5
Commissioners ensure information and resources are available for healthcare professionals to use during consultations with people seeking advice about managing self-limiting RTIs. **2
Reduce antibiotic prescribing/antimicrobial resistance—general behaviors.7
* Providers only.** Commissioners only.
Table 2. Intervention and target group.
Table 2. Intervention and target group.
InterventionTarget Group
Public Health England Antibiotic Guardian [37]Patients
Prescribers
Community pharmacists and pharmacy staff
Providers
Commissioners
TARGET Antibiotics Toolkit (Treat Antibiotics Responsibly, Guidance, Education, Tools) [38]Patients
Prescribers
Community pharmacists and pharmacy staff
Providers
Commissioners
British Society for Antimicrobial Chemotherapy: Antibiotic Action [39]Patients
Prescribers
Community pharmacists and pharmacy staff
Providers
Commissioners
Treat Yourself Better [40]Patients
UK Department of Health and Public Health England Antimicrobial Prescribing and Stewardship Competencies [41]Prescribers
Providers
Commissioners
theLearningpharmacy.com [42]Community pharmacists and pharmacy staff
Royal College of Nursing (RCN) and Infection Prevention Society (IPS) Infection Prevention and Control Commissioning Toolkit [43]Providers
Stemming the Tide of Antibiotic Resistance (STAR) e-learning [44]Prescribers
Managing Acute Respiratory Tract Infections (MARTI) e-learning [45]Prescribers
Public Health England ‘Beat the Bugs’ course [46]Patients
NHS England Patient Safety Alert—addressing antimicrobial resistance through implementation of an antimicrobial stewardship program [47]Providers
Commissioners
Public Health England Keep Antibiotics Working campaign [48]Patients
Providers
Commissioners
NHS England Quality Premium: 2016/17 Guidance for CCGs [49]Providers
Commissioners
Public Health England Fingertips platform [50]Providers
Commissioners
PrescQIPP Antimicrobial Stewardship [51]Prescribers
Providers
Commissioners
UK Chief Medical Officer letter to high prescribers of antibiotics [52]Prescribers
Self Care Forum: Self Care Week [53]Patients
Providers
Commissioners
The Health and Social Care Act (HSCA) 2008. Code of Practice on the prevention and control of infections and related guidance [54]Providers
Commissioners
NICE Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use [NG15] [17] Prescribers
Community pharmacists and pharmacy staff
Providers
Commissioners
NICE Infection Prevention and Control [QS61] [27]Patients
Prescribers
Providers
Commissioners
UK Five Year Antimicrobial Resistance Strategy 2013 to 2018 [15]Prescribers
Providers
Commissioners
NHS website advice on common cold [55]Patients
NICE Antimicrobial stewardship: changing risk-related behaviors in the general population [NG63] [23]Prescribers
Community pharmacists and pharmacy staff
Providers
Commissioners
Center for Pharmacy Postgraduate Education distance course: Antibacterial resistance—a global threat to public health: the role of the pharmacy team [56]Prescribers
Community pharmacists and pharmacy staff
UK Clinical Pharmacy Association / Royal Pharmaceutical Society—professional practice curriculum [57]Prescribers
FeverPAIN [58]Prescribers
Public health England Managing Common Infections Guidance [28]Prescribers
NICE Respiratory tract infections (self-limiting): prescribing antibiotics [CG69] [59]Patients
Prescribers
NICE Antimicrobial Stewardship [QS121] [29]Prescribers
Providers
Commissioners
Self Care Forum: Factsheet 7 (Cough in Adults); Factsheet 12 (Common Cold) [60]Patients
OpenPrescribing.net [61]Providers
Commissioners
CENTOR [62]Prescribers
Health Education England ‘Antimicrobial Resistance: A Guide for GPs’ [63]Prescribers
NICE Sinusitis (acute): antimicrobial prescribing [NG79] [24]Patients
Prescribers
NICE Sore throat (acute): antimicrobial prescribing [NG84] [26]Prescribers
Department of Health & Social Care ‘Take Care not Antibiotics’ videos [64]Patients
Patient.info webpages on colds, sore throats, antibiotics, bronchitis and sinusitis [65]Patients
Health Education England ‘Awareness of Antimicrobial Resistance (AMR) Animation’ [66]Patients
Royal Pharmaceutical Society: Antimicrobial Stewardship Quick Reference Guide [31]Community pharmacists and pharmacy staff
Commissioners
Table 3. Interrater reliability.
Table 3. Interrater reliability.
KappaPABAK
Behaviors0.890.90
COM-B0.680.75
TDF0.600.77
Intervention types0.670.76
Policy options0.770.88
BCTs0.690.95
Table 4. Frequency of types in interventions.
Table 4. Frequency of types in interventions.
Intervention TypeNumber of Interventions (Max 39)Example of Coded Intervention
Training32“Ensure resources and advice are also available for people who are prescribed or supplied with antimicrobials, to ensure they take them as instructed by their healthcare professional. This should include taking the correct dose for the time specified and via the correct route.”
Education29“Taking antibiotics encourages harmful bacteria that live inside you to become resistant.”
Enablement25Resources listed to become an Antibiotic Guardian.
Persuasion18“Once the bugs are resistant, the antibiotics don’t work and we’re back in the ‘the Stone Age.’”
Incentivization6CPD points for completing a course.
Modeling3Film of a consultation where a physician manages a patient’s expectations.
Coercion3“If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics.”
Environmental restructuring1“Service providers (such as hospitals and dental practices) ensure that prescribers of antimicrobials have access to electronic prescribing systems that link indication with the antimicrobial prescription.”
Restriction0-
Table 5. Frequency of Behavior Change Techniques (BCTs) in interventions.
Table 5. Frequency of Behavior Change Techniques (BCTs) in interventions.
BCTNumber of Interventions Identified in (Max 39)Example of BCT Identified in an Intervention
Instruction on how to perform the behavior33“Rest, drink plenty of fluids, take pain relievers, such as paracetamol or ibuprofen, and talk to your pharmacist for advice on getting the relief you need.”
Information about health consequences25“Most common winter ailments, such as colds, sore throat, cough, sinusitis, or painful middle ear infection (earache), can’t be treated with antibiotics.”
Adding objects to the environment11Providing decision aids for antibiotic prescription.
Credible source11Letter from the Chief Medical Officer.
Action planning8Provision of an implementation spreadsheet in Antibiotic stewardship Quality Standard QS121.
Feedback on the behavior8Comparative data on national and local prescribing.
Identification of self as role model8“All pharmacists, regardless of setting, have AMS obligations and with over 1.6 million visits each day, community pharmacy teams have a key role.”
Information about social environmental consequences6“Antibiotic prescribing is a huge cost for the NHS. For instance annual prescribing for acute cough alone exceeds £15 million (NICE, 2008).”
Feedback on outcome(s) of the behavior6National and local data on prescribing outcomes.
Social support (practical)5“If you are not sure, ask your doctor, nurse practitioner or pharmacist for help and advice.”
Social comparison4“Ranking - Looks at how you compare, and rank, against the 211 CCGs nationally, your 10 ‘cluster’ CCGs (most like you), and within the PrescQIPP Community. We also provide the Range within these groups”
Demonstration of the behavior4Video clip of a consultation showing GPs explaining why antibiotics are not useful to treat a virus.
Salience of consequences4“If no antibiotics work, it will be like going back to the 1930s.”
Self-monitoring of behavior4“Review and monitor how well the guideline is being implemented through the project group.”
Future punishment3“The rapid spread of multi-drug resistant (MDR) bacteria means that we could be close to reaching a point where we may not be able to prevent or treat everyday infections or diseases.”
Self-monitoring of outcomes of behavior3Testing GPs knowledge on completion of an RTI self-management training module.
Non-specific reward2“Certificate for course completion.”
Prompts/cues2‘Choose self-care for life’ posters/web buttons/TV screens.
Material reward1“Reward for improvements in service quality.”
Behavioral practice/rehearsal1“Rehearsal and discussion of what to do when have cough or cold”
Behavioral substitution1Recommending providing patients with a leaflet on UTI management rather than prescribing antibiotics.
Commitment1Making a pledge, e.g., “I will ensure all prescribers in my practice including locums have easy access to the local antibiotic guidance.”
Focus on past success1Reminding pharmacists about their experience in providing self-care advice.
Framing reframing1Suggesting that leaflets are viewed as a tool for self-management rather than a parting gift.
Goal setting (behavior)1“Quality standards are intended to drive up the quality of care, and so achievement levels of 100% should be aspired to.”
Pharmacological support1“Talk to your local pharmacist about other ways to help with symptoms, such as taking painkillers.”
Problem solving1“Identifying barriers to change in prescribers own practice.”
Pros and cons1Conducting a SWOT analysis (Strengths, Weaknesses, Opportunities, Threats) in planning implementing a patients self-care intervention.
Restructuring the physical environment1“Electronic prescribing systems that link indication with the antimicrobial prescription.”
Social reward1“Thank you for your ongoing commitment to reduce antimicrobial resistance (AMR) and drug resistance infections.”
Table 6. Frequency of interventions targeting influences on behavior.
Table 6. Frequency of interventions targeting influences on behavior.
Number of Interventions (Max 39)
COM-B
Psychological capability38
Reflective motivation22
Physical opportunity12
Automatic motivation8
Social opportunity6
Physical capability1
TDF
Knowledge33
Skills16
Beliefs about consequences15
Environmental Context and Resources13
Behavioral Regulation12
Intention11
Social Professional Role and Identity7
Social Influences6
Reinforcement5
Memory, Attention, and Decision Making4
Emotion3
Optimism2
Beliefs about capabilities1
Goals1

Share and Cite

MDPI and ACS Style

Atkins, L.; Chadborn, T.; Bondaronek, P.; Ashiru-Oredope, D.; Beech, E.; Herd, N.; de La Morinière, V.; González-Iraizoz, M.; Hopkins, S.; McNulty, C.; et al. Content and Mechanism of Action of National Antimicrobial Stewardship Interventions on Management of Respiratory Tract Infections in Primary and Community Care. Antibiotics 2020, 9, 512. https://doi.org/10.3390/antibiotics9080512

AMA Style

Atkins L, Chadborn T, Bondaronek P, Ashiru-Oredope D, Beech E, Herd N, de La Morinière V, González-Iraizoz M, Hopkins S, McNulty C, et al. Content and Mechanism of Action of National Antimicrobial Stewardship Interventions on Management of Respiratory Tract Infections in Primary and Community Care. Antibiotics. 2020; 9(8):512. https://doi.org/10.3390/antibiotics9080512

Chicago/Turabian Style

Atkins, Lou, Tim Chadborn, Paulina Bondaronek, Diane Ashiru-Oredope, Elizabeth Beech, Natalie Herd, Victoria de La Morinière, Marta González-Iraizoz, Susan Hopkins, Cliodna McNulty, and et al. 2020. "Content and Mechanism of Action of National Antimicrobial Stewardship Interventions on Management of Respiratory Tract Infections in Primary and Community Care" Antibiotics 9, no. 8: 512. https://doi.org/10.3390/antibiotics9080512

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop